Extended Longevity
Early Stage
Phytotherapeutic Formulation Protocol
Overview
Raised: $60,717
Total Commitments ($USD)
Platform
Wefunder
Start Date
10/03/2022
Close Date
12/23/2022
Min. Goal
$50,000
Max. Goal
$107,000
Min. Investment
$100
Security Type
Equity - Preferred
Series
Pre-Seed
SEC Filing Type
RegCF
Price Per Share
$5.00
Pre-Money Valuation
$45,000,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
12/31/2022
Days Remaining
Funded
% of Min. Goal
121%
% of Max. Goal
57%
Likelihood of Max
Funded
Avg. Daily Raise
$750
# of Investors
55
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2019
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2C
Margin
High
Capital Intensity
Low
Extended Longevity, with a valuation of $45 million, is raising funds on Wefunder. The company has developed the technology to control the internal biological factors and target them to delay aging. The Extended Longevity technology focuses on decelerating the biomarkers of aging and has developed several products to reverse aging, extend life, and optimize health. The products are already in production at the company’s facilities in Maui, Hawaii, and currently selling. Steven M. Schorr founded Extended Longevity in October 2019. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $107,000. The campaign proceeds will be used for the expansion of the Phytotherapeutic extraction, facilities, and increased inventory, marketing, research and development, and general corporate purposes.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$31,073 |
$8,513 |
|
COGS |
$2,410 |
$693 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-65,702 |
$-59,867 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$5,025 |
$3,245 |
|
Accounts Receivable |
$7,269 |
$2,791 |
|
Total Assets |
$41,128 |
$24,849 |
|
Short-Term Debt |
$172,497 |
$95,816 |
|
Long-Term Debt |
$5,300 |
$0 |
|
Total Liabilities |
$177,797 |
$95,816 |
Financials as of: 10/03/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Are you the founder of Extended Longevity? Create your account today to claim this raise page.